CarloBartoliMD

PubMed

• Contralateral Thoracotomy With Extracorporeal Circulation for Reoperative Resection of a Kommerell Diverticulum.
  Rajakumar, C., Ziemer, G., Bartoli, C., Elmore, J.> ;World Journal for Pediatric & Congenital Heart Surgery. 2024 Mar 1
• 8 citations
  COMPETENCE Trial: The EVAHEART 2 continuous flow left ventricular assist device.
  Steven R Allen, Mark S Slaughter, Mustafa M Ahmed, Carlo R Bartoli, Ravi Dhingra, Gregory F Egnaczyk, Sanjeev K Gulati, Michael S Kiernan, Claudius Mahr, Dan M Meyer, ...> ;The Journal of Heart and Lung Transplantation. 2023 Jan 1
• 3 citations
  Kinetic and Dynamic Effects on Degradation of von Willebrand Factor.
  Choon-Sik Jhun, Lichong Xu, Christopher Siedlecki, Carlo R Bartoli, Eric Yeager, Branka Lukic, Christopher M Scheib, Raymond Newswanger, Joshua P Cysyk, Chan Shen, Kar...> ;ASAIO Journal. 2023 May 1
• 7 citations
  Impact of hepatopulmonary syndrome in liver transplantation candidates and the role of angiogenesis.
  Steven M Kawut, Michael J Krowka, Kimberly A Forde, Nadine Al-Naamani, Karen L Krok, Mamta Patel, Carlo R Bartoli, Margaret Doyle, Jude Moutchia, Grace Lin, Jae K Oh, ...> ;The European Respiratory Journal. 2022 Aug 1
• 4 citations
  Patient-specific severity of von Willebrand factor degradation identifies patients with a left ventricular assist device at high risk for bleeding.
  Samson Hennessy-Strahs, Jooeun Kang, Eric Krause, Robert D Dowling, J Eduardo Rame, Carlo R Bartoli> ;The Journal of Thoracic and Cardiovascular Surgery. 2024 Jan 1
• 5 citations
  Pathologic von Willebrand factor degradation is a major contributor to left ventricular assist device-associated bleeding: pathophysiology and evolving clinical manage...
  Carlo R. Bartoli> ;Annals of Cardiothoracic Surgery. 2021 May 1
• 3 citations
  Reinventing the displacement left ventricular assist device in the continuous-flow era: TORVAD, the first toroidal-flow left ventricular assist device.
  Carlo R. Bartoli, Jeffrey R. Gohean, Richard W. Smalling> ;Annals of Cardiothoracic Surgery. 2021 Mar 1
• 7 citations
  Abnormalities in the Von Willebrand-Angiopoietin Axis Contribute to Dysregulated Angiogenesis and Angiodysplasia in Children With a Glenn Circulation
  Carlo R. Bartoli, Samson Hennessy-Strahs, Robert D. Dowling, J. William Gaynor, Andrew C. Glatz> ;JACC. Basic to Translational Science. 2021 Mar 1
• 8 citations
  Toward a Standard Practice to Quantify von Willebrand Factor Degradation During Left Ventricular Assist Device Support.
  Samson Hennessy-Strahs, Christian A. Bermudez, Michael A. Acker, Carlo R. Bartoli> ;The Annals of Thoracic Surgery. 2021 Oct 1
• 6 citations
  Decreased RPM reduces von Willebrand factor degradation with the EVAHEART LVAS: implications for device-specific LVAD management.
  Carlo R. Bartoli, Jooeun Kang, Tadashi Motomura> ;Journal of Cardiac Surgery. 2020 Jul 1
• 13 citations
  A Novel Toroidal-Flow Left Ventricular Assist Device Minimizes Blood Trauma: Implications of Improved Ventricular Assist Device Hemocompatibility
  Carlo R. Bartoli, Samson Hennessy-Strahs, Jeff Gohean, Maryann Villeda, Erik R. Larson, Raul G. Longoria, Mark Kurusz, Michael A. Acker, Richard W. Smalling> ;The Annals of Thoracic Surgery. 2019 Jun 1
• 13 citations
  Fetal hypoxemia causes abnormal myocardial development in a preterm ex utero fetal ovine model.
  , , , , , , , , , , , , , , , > ;JCI Insight. 2018 Dec 20
• 28 citations
  Clinical and In Vitro Evidence That Left Ventricular Assist Device-Induced von Willebrand Factor Degradation Alters Angiogenesis.
  Carlo R. Bartoli, David M. Zhang, Samson Hennessy-Strahs, Jooeun Kang, David J. Restle, Christian A. Bermudez, Pavan Atluri, Michael A. Acker> ;Circulation. Heart Failure. 2018 Sep 1
• 30 citations
  Clinical and In Vitro Evidence That Subclinical Hemolysis Contributes to LVAD Thrombosis
  Carlo R. Bartoli, David M. Zhang, Jooeun Kang, Samson Hennessy-Strahs, David J. Restle, Jessica L. Howard, Gretchen Redline, Christian A. Bermudez, Pavan Atluri, Micha...> ;The Annals of Thoracic Surgery. 2017 Sep 21
• 47 citations
  Continuous-Flow LVAD Support Causes a Distinct Form of Intestinal Angiodysplasia.
  Jooeun Kang, Samson Hennessy-Strahs, Pawel Kwiatkowski, Christian A. Bermudez, Michael A. Acker, Pavan Atluri, Patrick I. McConnell, Carlo R. Bartoli> ;Circulation Research. 2017 Sep 29
• 62 citations
  Hemodynamic Support With a Microaxial Percutaneous Left Ventricular Assist Device (Impella) Protects Against Acute Kidney Injury in Patients Undergoing High-Risk Percu...
  Michael P. Flaherty, Sadip Pant, Samir V. Patel, Tyler Kilgore, Sujith Dassanayaka, John H Loughran, Wasiq Rawasia, Buddhadeb Dawn, Allen Cheng, Carlo R. Bartoli> ;Circulation Research. 2017 Feb 17
• 10 citations
  Continuous-Flow Left Ventricular Assist Device Support Improves Myocardial Supply:Demand in Chronic Heart Failure.
  Kevin G. Soucy, Carlo R. Bartoli, Dustin Phillips, Guruprasad A. Giridharan, Michael A. Sobieski, William B. Wead, Robert D. Dowling, Zhongjun J. Wu, Sumanth D. Prabhu...> ;Annals of Biomedical Engineering. 2017 Feb 6
• 37 citations
  Left Ventricular Assist Device Design Reduces von Willebrand Factor Degradation: A Comparative Study Between the HeartMate II and the EVAHEART Left Ventricular Assist ...
  Carlo R. Bartoli, Jooeun Kang, David M. Zhang, Jessica L. Howard, Michael A. Acker, Pavan Atluri, Tadashi Motomura> ;The Annals of Thoracic Surgery. 2017 Apr 1
• Antibody-Based Protection of von Willebrand Factor Degradation.
  Peter J. Lenting, Cécile V. Denis, Sophie Susen, Eric Van Belle> ;JACC. Heart Failure. 2016 Jun 1
• 1 citations
  Reply: Antibody-Based Protection of von Willebrand Factor Degradation.
  Carlo R. Bartoli> ;JACC. Heart Failure. 2016 Jun 1
• 27 citations
  Reduced continuous-flow left ventricular assist device speed does not decrease von Willebrand factor degradation
  Jooeun Kang, David M. Zhang, David J. Restle, Faouzi Kallel, Michael A. Acker, Pavan Atluri, Carlo R. Bartoli> ;The Journal of Thoracic and Cardiovascular Surgery. 2016 Jun 1
• 52 citations
  Inhibition of ADAMTS-13 by Doxycycline Reduces von Willebrand Factor Degradation During Supraphysiological Shear Stress: Therapeutic Implications for Left Ventricular ...
  Carlo R. Bartoli, Jooeun Kang, David J. Restle, David M. Zhang, Cameron Shabahang, Michael A. Acker, Pavan Atluri> ;JACC. Heart Failure. 2015 Nov 1
• 4 citations
  Do patients with a continuous-flow left ventricular assist device benefit from induced-pulsatility or are we just spinning our wheels?
  Carlo R. Bartoli, Pavan Atluri> ;The Journal of Thoracic and Cardiovascular Surgery. 2015 Oct 1
• 24 citations
  Preclinical Models for Translational Investigations of Left Ventricular Assist Device-Associated von Willebrand Factor Degradation
  David J. Restle, David M. Zhang, George Hung, Jessica L. Howard, Faouzi Kallel, Michael A. Acker, Pavan Atluri, Carlo R. Bartoli> ;Artificial Organs. 2015 Jul 1
• 12 citations
  Hemodynamic changes and retrograde flow in LVAD failure.
  Guruprasad A. Giridharan, Steven C. Koenig, Kevin G. Soucy, Young Choi, Tohid Pirbodaghi, Carlo R. Bartoli, Gretel Monreal, Michael A. Sobieski, Erin M. Schumer, Allen...> ;ASAIO Journal. 2015 May 1
• Join now to see all

Lectures

• Mechanistic Insight Into the Role of the von Willebrand Factor-Angiopoietin-Axis in Pulmonary Arteriovenous Malformations in Children With a Glenn Circulation 
  2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019